Total Reports
219
FDA CVM filings
Dog /
FDA CVM · 2025 release 219 reports on file
Spaniel - Tibetan - FDA Adverse Event Profile
Adverse-event records for Spaniel - Tibetan (Dog) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Spaniel - Tibetan ranks #178 by report volume among dog breeds - 11 of 219 reports (5.0%) recorded a death outcome.
- #178
- most-reported dog breed
- 5.0%
- death-coded report share
- 55
- Vomiting - top reaction
- 7.1 yr
- average age at report
Report counts track breed popularity and reporting activity, not real-world risk, read this alongside how common the breed is.
Deaths Reported
11
of 219 reports
Death Rate
5.0%
death-coded share
Avg Age at Report
7.1 yr
7.8 kg avg weight
Death-Coded Outcome Share
Spaniel - Tibetan death-coded reports 5.0%
Cross-breed median
5.0% of 219 spaniel - tibetan reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 7.8 kg (17.2 lbs)
Top Reported Reactions
Vomiting 55
Lethargy (see also Central nervous system depression in 'Neurological') 29
Emesis 21
Lack of efficacy (ectoparasite) - flea 17
Diarrhoea 16
Lack of efficacy (endoparasite) - hookworm 13
Behavioural disorder NOS 13
Digestive tract disorder NOS 10
Most Referenced Drugs
Milbemycin Oxime + Spinosad 47
Spinosad 21
Afoxolaner 17
Pyrantel Pamoate;Sarolaner 17
Ivermectin + Pyrantel As Pamoate Salt 11
Fluralaner Chew Tablets 11
Fluralaner 13.64% 12-Week Chew 10
Pimobendan 6
Outcome Breakdown
Recovered/Normal
86 (43.4%)
Ongoing
52 (26.3%)
Outcome Unknown
44 (22.2%)
Euthanized
6 (3.0%)
Died
5 (2.5%)
Recovered with Sequela
5 (2.5%)
Gender Distribution
Male 124 (56.6%)
Female 87 (39.7%)
Unknown 8 (3.7%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2010 | 12 | |
| 2011 | 12 | |
| 2012 | 17 | |
| 2013 | 17 | |
| 2014 | 20 | |
| 2015 | 20 | |
| 2016 | 14 | |
| 2017 | 23 | |
| 2018 | 8 | |
| 2019 | 9 | |
| 2020 | 13 | |
| 2021 | 11 | |
| 2022 | 12 | |
| 2023 | 11 | |
| 2024 | 11 | |
| 2025 | 9 | |
Spaniel - Tibetan Pet Health Insights
Spaniel - Tibetan accounts for 219 FDA adverse event reports, ranking #178 by volume among dog breeds, with 11 reports (5.0%) coded as a death outcome. Mean age at report: 7.1 years, average weight 7.8 kg (17.2 lbs).
Top reported signs: Vomiting (55), Lethargy (see also Central nervous system depression in 'Neurological') (29), Emesis (21). Most-referenced drug: Milbemycin Oxime + Spinosad (47 reports), followed by Spinosad (21) and Afoxolaner (17).
Outcome coding on 198 status-recorded reports is dominated by Recovered/Normal (43.4%). Annual submissions ranged 2,010-2,025 across 16 years on file.
Dog Breeds With a Similar Report Volume
Griffon - French Wire-haired Pointing
218 reports · 0.5% death rate
Treeing Feist
215 reports · 1.9% death rate
Setter - Gordon
227 reports · 5.3% death rate
Coonhound - Redbone
210 reports · 3.8% death rate
Terrier - Norwich
232 reports · 3.0% death rate
Retriever - Nova Scotia Duck Tolling
240 reports · 1.7% death rate
Frequently Asked Questions
How many FDA adverse event reports involve Spaniel - Tibetan? ▼
There are 219 adverse event reports involving Spaniel - Tibetan in the FDA database, with 11 reports involving death (5.0% death rate). Spaniel - Tibetan ranks #178 by report volume.
What are the most common adverse reactions reported for Spaniel - Tibetan? ▼
The most commonly reported adverse reactions for Spaniel - Tibetan are Vomiting (55 reports), Lethargy (see also Central nervous system depression in 'Neurological') (29 reports), Emesis (21 reports), Lack of efficacy (ectoparasite) - flea (17 reports), Diarrhoea (16 reports).
What drugs are most frequently associated with Spaniel - Tibetan adverse events? ▼
The drugs most frequently referenced in Spaniel - Tibetan adverse event reports are Milbemycin Oxime + Spinosad (47 reports), Spinosad (21 reports), Afoxolaner (17 reports), Pyrantel Pamoate;Sarolaner (17 reports), Ivermectin + Pyrantel As Pamoate Salt (11 reports).
What is the average age of Spaniel - Tibetan in adverse event reports? ▼
The average age of Spaniel - Tibetan at the time of adverse event reports is 7.1 years, with an average weight of 7.8 kg (17.2 lbs).
Does a high number of adverse event reports mean Spaniel - Tibetan is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Spaniel - Tibetan safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.